REQUEST A DEMO
Total
USD $0.00
Search more companies

Inter Pharma Public Company Limited (Thailand)

Main Activities: Other Food Manufacturing | Grocery Stores
Full name: Inter Pharma Public Company Limited Profile Updated: August 02, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English & Thai Download a sample report

Inter Pharma Public Company Limited is an enterprise located in Thailand, with the main office in Bangkok , Special Governed District of. The enterprise currently operates in the Other Food Manufacturing sector. The enterprise was incorporated on 2006. There was a net sales revenue increase of 8.32% reported in Inter Pharma Public Company Limited’s latest financial highlights for Q2C2020. Its’ total assets recorded a growth of 154.12%. The net profit margin of Inter Pharma Public Company Limited increased by 6.99% in 2020.

Legal Address
140/9 Itf Tower 9th Floor Silom Road,Suriyawong
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10500

Contact Details: Purchase the Inter Pharma Public Company Limited report to view the information.

Website: http://www.interpharma.co.th

Basic Information
Outstanding Shares:
Purchase the Inter Pharma Public Company Limited report to view the information.
Financial Auditors:
Purchase the Inter Pharma Public Company Limited report to view the information.
Incorporation Date:
2006
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
2.9%
Company Performance
Financial values in the chart are available after Inter Pharma Public Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
8.32%
Total operating revenue
7.81%
Operating profit (EBIT)
84.63%
EBITDA
83.49%
Net Profit (Loss) for the Period
84.95%
Total assets
154.12%
Total equity
258.54%
Operating Profit Margin (ROS)
8.96%
Net Profit Margin
6.99%
Return on Equity (ROE)
-6.8%
Debt to Equity Ratio
-10.38%
Quick Ratio
4.93%
Cash Ratio
4.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?